Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Oct;33(10):1822–1823. doi: 10.1128/aac.33.10.1822

Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.

A Padula 1, H F Chambers 1
PMCID: PMC172764  PMID: 2686548

Abstract

The efficacy of cilofungin (LY121019) for aortic valve endocarditis caused by Candida albicans in rabbits was studied. Vegetation titers were similar for cilofungin-treated and untreated rabbits. No rabbit survived beyond 5 days in either group. All rabbits given amphotericin B survived, and titers were reduced. Cilofungin was ineffective in this model.

Full text

PDF
1822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calderone R. A., Rotondo M. F., Sande M. A. Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun. 1978 Apr;20(1):279–289. doi: 10.1128/iai.20.1.279-289.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Durack D. T., Beeson P. B. Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972 Feb;53(1):50–53. [PMC free article] [PubMed] [Google Scholar]
  3. Gordee R. S., Simpson P. J. Relationships of x-irradiation to the enhancement of Candida albicans infections. J Bacteriol. 1967 Jul;94(1):6–12. doi: 10.1128/jb.94.1.6-12.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gordee R. S., Zeckner D. J., Ellis L. F., Thakkar A. L., Howard L. C. In vitro and in vivo anti-Candida activity and toxicology of LY121019. J Antibiot (Tokyo) 1984 Sep;37(9):1054–1065. doi: 10.7164/antibiotics.37.1054. [DOI] [PubMed] [Google Scholar]
  5. Lorian V., Zak O., Kunz S., Vaxelaire J. Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin. Antimicrob Agents Chemother. 1984 Mar;25(3):311–315. doi: 10.1128/aac.25.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mizoguchi J., Saito T., Mizuno K., Hayano K. On the mode of action of a new antifungal antibiotic, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae. J Antibiot (Tokyo) 1977 Apr;30(4):308–313. doi: 10.7164/antibiotics.30.308. [DOI] [PubMed] [Google Scholar]
  7. Rubinstein E., Noriega E. R., Simberkoff M. S., Rahal J. J., Jr Tissue penetration of amphotericin B in Candida endocarditis. Chest. 1974 Oct;66(4):376–377. doi: 10.1378/chest.66.4.376. [DOI] [PubMed] [Google Scholar]
  8. Spitzer E. D., Travis S. J., Kobayashi G. S. Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):80–81. doi: 10.1007/BF01962183. [DOI] [PubMed] [Google Scholar]
  9. WALKER W. F., HAMBURGER M. A study of experimental, staphylococcal endocarditis in dogs. I. Production of the disease, its natural history, and tissue bacteriology. J Lab Clin Med. 1959 Jun;53(6):931–941. [PubMed] [Google Scholar]
  10. Yamaguchi H., Hiratani T., Iwata K., Yamamoto Y. Studies on the mechanism of antifungal action of aculeacin A. J Antibiot (Tokyo) 1982 Feb;35(2):210–219. doi: 10.7164/antibiotics.35.210. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES